Article 12 Dec 2025 Alberta Securities Commission Publishes 2025 Corporate Finance Disclosure Report Canada Commercial
Article 07 Aug 2025 Pilule empoisonnée rétroactive : l'Alberta Securities Commission publie les motifs de sa décision d'interdire les opérations Canada Commercial
Article 31 Jul 2025 Alberta Securities Commission Releases Reasons For Cease-Trading Retroactive Poison Pill Canada Commercial
Article 09 Jul 2025 Considérations clés relativement aux « propositions supérieures » au Canada Canada Commercial
Article 11 Feb 2025 L'Alberta Securities Commission publie son Corporate Finance Disclosure Report pour 2024 Canada Commercial
Article 20 Jan 2025 Alberta Securities Commission Publishes 2024 Corporate Finance Disclosure Report Canada Commercial
Article 17 Dec 2024 Pilule empoisonnée rétroactive : l'Alberta Securities Commission prononce une interdiction d'opérations Canada Commercial
Article 05 Dec 2024 ACVM : Modèle D'accès Aux Documents D'information Continue D'émetteurs Assujettis Qui Ne Sont Pas Des Fonds D'investissement Canada Commercial
Article 29 Nov 2024 CSA Proposes Access Model For Continuous Disclosure Documents Of Non-Investment Fund Reporting Issuers Canada Commercial
Article 19 Nov 2024 Alberta Securities Commission Cease-Trades Retroactive Poison Pill Canada Commercial
Article 06 Feb 2024 Exploring The Headwaters: Gaining Insight To Advance Women GCs On Boards Canada Commercial
Article 25 Jan 2024 CSA Finalizes Amendments To Implement Access Model For Prospectuses Of Non-Investment Fund Reporting Issuers Canada Commercial
Article 25 Jun 2021 Alberta Securities Commission Considers Financing Adequacy And Shareholder Protections In Unique Take-Over Bid Canada Commercial
Article 03 Feb 2021 Special Edition: Public M&A Trends: Looking Back And Moving Forward Canada Commercial
Article 03 Feb 2021 Continuity Podcast – Special Edition: Public M&A Trends: Looking Back And Moving Forward Canada Commercial